{"disease":{"id":"schizophrenia-cerebellar-ataxia","name":"schizophrenia cerebellar ataxia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02566759","title":"A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":110,"lead_sponsor_name":"Neurocrine Biosciences","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}